BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 23224996)

  • 1. The PMP22 gene and its related diseases.
    Li J; Parker B; Martyn C; Natarajan C; Guo J
    Mol Neurobiol; 2013 Apr; 47(2):673-98. PubMed ID: 23224996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene.
    Taioli F; Cabrini I; Cavallaro T; Acler M; Fabrizi GM
    Brain; 2011 Feb; 134(Pt 2):608-17. PubMed ID: 21252112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies.
    Gabriel JM; Erne B; Pareyson D; Sghirlanzoni A; Taroni F; Steck AJ
    Neurology; 1997 Dec; 49(6):1635-40. PubMed ID: 9409359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T; Garcia CA; Reiter LT; Lupski JR
    Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
    Naef R; Suter U
    Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of PMP22 in Slovak patients with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies.
    Resko P; Radvansky J; Odnogova Z; Baldovic M; Minarik G; Polakova H; Palffy R; Kadasi L
    Gen Physiol Biophys; 2011 Dec; 30(4):379-88. PubMed ID: 22131320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies.
    Bort S; Nelis E; Timmerman V; Sevilla T; Cruz-Martínez A; Martínez F; Millán JM; Arpa J; Vílchez JJ; Prieto F; Van Broeckhoven C; Palau F
    Hum Genet; 1997 Jun; 99(6):746-54. PubMed ID: 9187667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies.
    van Paassen BW; van der Kooi AJ; van Spaendonck-Zwarts KY; Verhamme C; Baas F; de Visser M
    Orphanet J Rare Dis; 2014 Mar; 9():38. PubMed ID: 24646194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural distribution of PMP22 in Charcot-Marie-Tooth disease type 1A.
    Haney C; Snipes GJ; Shooter EM; Suter U; Garcia C; Griffin JW; Trapp BD
    J Neuropathol Exp Neurol; 1996 Mar; 55(3):290-9. PubMed ID: 8786387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral Myelin Protein 22 Gene Mutations in Charcot-Marie-Tooth Disease Type 1E Patients.
    Jung NY; Kwon HM; Nam DE; Tamanna N; Lee AJ; Kim SB; Choi BO; Chung KW
    Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation.
    Giambonini-Brugnoli G; Buchstaller J; Sommer L; Suter U; Mantei N
    Neurobiol Dis; 2005 Apr; 18(3):656-68. PubMed ID: 15755691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid detection of duplication/deletion of the PMP22 gene in patients with Charcot-Marie-Tooth disease Type 1A and hereditary neuropathy with liability to pressure palsy by real-time quantitative PCR using SYBR Green I dye.
    Kim SW; Lee KS; Jin HS; Lee TM; Koo SK; Lee YJ; Jung SC
    J Korean Med Sci; 2003 Oct; 18(5):727-32. PubMed ID: 14555828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis and genotype/phenotype correlation in Turkish Charcot-Marie-Tooth Type 1 and HNPP patients.
    Bissar-Tadmouri N; Parman Y; Boutrand L; Deymeer F; Serdaroglu P; Vandenberghe A; Battaloglu E
    Clin Genet; 2000 Nov; 58(5):396-402. PubMed ID: 11140841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of peripheral myelin protein 22 for nerve compression and neural regeneration: a review.
    Hui-Chou HG; Hashemi SS; Hoke A; Dellon AL
    J Reconstr Microsurg; 2011 Jan; 27(1):67-74. PubMed ID: 20976668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The peripheral myelin protein 22 and epithelial membrane protein family.
    Jetten AM; Suter U
    Prog Nucleic Acid Res Mol Biol; 2000; 64():97-129. PubMed ID: 10697408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PMP22 expression in dermal nerve myelin from patients with CMT1A.
    Katona I; Wu X; Feely SM; Sottile S; Siskind CE; Miller LJ; Shy ME; Li J
    Brain; 2009 Jul; 132(Pt 7):1734-40. PubMed ID: 19447823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal dominant Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies: detection of the recombination in Slovene patients and exclusion of the potentially recessive Thr118Met PMP22 point mutation.
    Leonardis L; Zidar J; Ekici A; Peterlin B; Rautenstrauss B
    Int J Mol Med; 1998 Feb; 1(2):495-501. PubMed ID: 9852256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies.
    Aarskog NK; Vedeler CA
    Hum Genet; 2000 Nov; 107(5):494-8. PubMed ID: 11140948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral myelin protein 22 gene duplication with atypical presentations: a new example of the wide spectrum of Charcot-Marie-Tooth 1A disease.
    Mathis S; Corcia P; Tazir M; Camu W; Magdelaine C; Latour P; Biberon J; Guennoc AM; Richard L; Magy L; Funalot B; Vallat JM
    Neuromuscul Disord; 2014 Jun; 24(6):524-8. PubMed ID: 24792522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pmp22 super-enhancer deletion causes tomacula formation and conduction block in peripheral nerves.
    Pantera H; Hu B; Moiseev D; Dunham C; Rashid J; Moran JJ; Krentz K; Rubinstein CD; Won S; Li J; Svaren J
    Hum Mol Genet; 2020 Jun; 29(10):1689-1699. PubMed ID: 32356557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.